NEA Management Company, LLC

TIMONIUM, MD · CIK 1512848 · 13F filing filed 2026-08-14

SEC-registered investment adviser since 2023 · limited liability company

Assets managed$35.6bn
Staff113 · 51 in investment roles
Main clients (by assets)Private funds 100%
Private funds27 · $35.6bn gross assets
Main officeMenlo Park, CA
Form ADV · 2026-08-26SEC adviser record

Kindprivate equity, venture, futures
Others nearbyMenlo Park, CA, New York, NY, London, Palm Beach, FL, San Francisco, CA, Lutherville Timonium, MD

As an employer

Offices in2 countries
Private fundsventure capital 26, private equity 1

Where they work

people there (dot area)number not reportedmain officeHover or tap a dot. Australian and UK companies are placed at their business or registered address, with their staff across the whole country.

Offices

From Form ADV: the main office and the other offices where it does advisory work (at most the 25 largest), with the people doing investment work at each. “About” is worked out: the firm's investment staff less its other offices. Each city links to the other managers there.

City	Country	People
Menlo Park, CA (main office)United States	United States	about 27
New York, NYUnited States	United States	21
LondonUnited Kingdom	United Kingdom	2
Palm Beach, FLUnited States	United States	1
San Francisco, CAUnited States	United States
Timonium, MDUnited States	United States

Map: places from GeoNames (CC BY 4.0), outlines from Natural Earth.

$1.6bn reported value -9.7% vs Q1 2026

26positions

89.8%in top 10

1 new 0 added 2 reduced 1 sold out vs Q1 2026

Holdings, Q2 2026

The small lines show how much was held over the last 4 quarters (adjusted for stock splits).

#	Security	Ticker	Shares	Value	% of portfolio	Change	Shares change
1	TREVI THERAPEUTICS INC COM TRVI	TRVI	13,222,228	$246.6m15.53%	15.53%	Unchanged
2	MBX BIOSCIENCES INC COM MBX	MBX	3,614,486	$199.5m12.56%	12.56%	Unchanged
3	MONTE ROSA THERAPEUTICS INC COM GLUE	GLUE	7,692,298	$186.2m11.72%	11.72%	Unchanged
4	CELCUITY INC COM CELC	CELC	1,710,561	$179.0m11.27%	11.27%	Reduced -575.0k	-575,000 -25.2%
5	SPYGLASS PHARMA INC COM SHS SGP	SGP	7,392,301	$164.6m10.36%	10.36%	Unchanged
6	SAVARA INC COM SVRA	SVRA	24,471,264	$150.7m9.49%	9.49%	Unchanged
7	ZENAS BIOPHARMA INC COM ZBIO	ZBIO	4,023,219	$102.1m6.43%	6.43%	Unchanged
8	COURSERA INC COM COUR	COUR	12,867,769	$72.6m4.57%	4.57%	Unchanged
9	AURINIA PHARMACEUTICALS INC COM AUPH	AUPH	3,969,834	$67.4m4.24%	4.24%	Unchanged
10	CRISPR THERAPEUTICS AG NAMEN AKT CRSP	CRSP	1,058,570	$57.7m3.64%	3.64%	Unchanged
11	ORIC PHARMACEUTICALS INC COM ORIC	ORIC	4,118,621	$44.6m2.81%	2.81%	Unchanged
12	PHATHOM PHARMACEUTICALS INC COM PHAT	PHAT	1,960,169	$21.3m1.34%	1.34%	Unchanged
13	KORRO BIO INC COM KRRO	KRRO	1,297,893	$17.1m1.08%	1.08%	Unchanged
14	X4 PHARMACEUTICALS INC COM COM		3,233,743	$15.1m0.95%	0.95%	Unchanged
15	CHAMPIONS ONCOLOGY INC COM NEW CSBR	CSBR	1,713,720	$10.6m0.66%	0.66%	Unchanged
16	NKARTA INC COM NKTX	NKTX	3,568,781	$10.1m0.64%	0.64%	Unchanged
17	CVRX INC COM CVRX	CVRX	1,954,440	$10.0m0.63%	0.63%	Reduced -71.6k	-71,643 -3.5%
18	BLACK DIAMOND THERAPEUTICS I COM BDTX	BDTX	4,448,757	$8.2m0.52%	0.52%	Unchanged
19	KARYOPHARM THERAPEUTICS INC COM NEW KPTI	KPTI	576,780	$5.6m0.35%	0.35%	New
20	INVENTIVA SA ADS IVA	IVA	1,462,586	$5.5m0.35%	0.35%	Unchanged
21	LEONABIO INC COM LONA	LONA	464,398	$4.3m0.27%	0.27%	Unchanged
22	SENTI BIOSCIENCES INC COM NEW COM NEW		3,775,615	$4.2m0.26%	0.26%	Unchanged
23	MARKER THERAPEUTICS INC COM NEW MRKR	MRKR	1,625,678	$2.4m0.15%	0.15%	Unchanged
24	ONKURE THERAPEUTICS INC COM CL A OKUR	OKUR	478,548	$2.2m0.14%	0.14%	Unchanged
25	IMAGENEBIO INC COM IMA	IMA	50,005	$295.0k0.02%	0.02%	Unchanged
26	GOSSAMER BIO INC COM GOSS	GOSS	1,000,000	$164.6k0.01%	0.01%	Unchanged

Sold out since Q1 2026

Security	Ticker	Shares held before	Value then
ARCELLX INC ACLX	ACLX	3,045,262	$349.7m3.0m shares